NCT00208923
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
- Locations
-
- Emory Universtiy Winship Cancer Institute Atlanta, Georgia, United States
Clinical trial condition
Hematologic Neoplasms
Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.
1,046 public trials
269 recruiting studies
Hematologic Neoplasms trial results
NCT00270881
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +24 more
- Locations
-
- Keio University School of Medicine Tokyo, Japan
NCT00881946
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
- Locations
-
- Prince of Wales Hospital Sydney, New South Wales, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
- Princess Margaret Hospital Toronto, Ontario, Canada
- Seoul National University Hospital Seoul, South Korea
Completed
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
NCT00312429
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
- Locations
-
- Duke University Durham, North Carolina, United States
NCT00476177
- Conditions
- Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancy, +5 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
NCT00333190
- Conditions
- ALL, AML, Blood Protein Disorders, +24 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00146614
- Conditions
- Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
- Locations
-
- Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00506857
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +11 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00144703
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
IUdR/BUdR Cell Cycle Labelling
NCT00042250
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States